Western Sahara Health Bulletin: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Western Sahara Health Bulletin.

Press releases published on October 22, 2026

6 hours ago

Korro Reports Best-in-Class Preclinical Data for KRRO-111 Demonstrating Potential to Benefit Lung and Liver Manifestations of Alpha-1 Antitrypsin Deficiency

Indeterminate GlobeNewswire

6 hours ago

Sagimet Biosciences Announces First Patient Dosed in AURORA Phase 3 U.S. Clinical Trial of Denifanstat for Moderate to Severe Acne

Indeterminate GlobeNewswire

6 hours ago

Medicenna to Present Preclinical Data on Its CD122 Superantagonist MDNA209 at The Promises of Treg and Interleukin-2 Therapies Conference

Indeterminate GlobeNewswire

6 hours ago

Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs

Indeterminate GlobeNewswire

7 hours ago

BioNTech treibt klinische Phase-3-Studie zu Pumitamig mit Gileads gegen TROP2-gerichtetem Antikörper-Wirkstoff-Konjugat Sacituzumab Govitecan bei Dreifach-Negativem Brustkrebs voran

Indeterminate GlobeNewswire

7 hours ago

BioNTech Advances Phase 3 Clinical Trial of Pumitamig in Combination with Gilead’s TROP2-Directed ADC Sacituzumab Govitecan in Triple-Negative Breast Cancer

Indeterminate GlobeNewswire

7 hours ago

Aveanna Announces Third Quarter 2026 Earnings Release Date and Conference Call

Indeterminate GlobeNewswire

7 hours ago

Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026

Indeterminate GlobeNewswire

7 hours ago

Cognition Therapeutics Announces Alignment with FDA on Pivotal Phase 3 Trial of Zervimesine (CT1812) in Dementia with Lewy Bodies

Indeterminate GlobeNewswire

8 hours ago

Rakovina Therapeutics and Variational AI Advance Brain-Penetrant ATR Program Toward Development Candidate Selection

Indeterminate GlobeNewswire

8 hours ago

KFSH Expands Capacity for Complex Care by Redesigning the Emergency Patient Journey

Indeterminate GlobeNewswire

9 hours ago

Levicept Announces Attendance at Major Healthcare Conferences in Q4

Indeterminate GlobeNewswire

10 hours ago

Nxera Pharma Submits Marketing Authorization Application for Vamorolone in South Korea for the Treatment of Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire

11 hours ago

Persica Pharmaceuticals presents antibiotic exposure-response analysis at the International Society of Pain & Neuroscience (ISPN) Annual Conference

Indeterminate GlobeNewswire

11 hours ago

Oculis Reports New Phase 2 ACUITY Biomarker Data Further Supporting Privosegtor’s Neuroprotective Potential in Optic Neuritis

Indeterminate GlobeNewswire

12 hours ago

Ipsen delivers outstanding sales growth in the first nine months of 2026 and further upgrades its full-year guidance

Indeterminate GlobeNewswire

12 hours ago

Ipsen réalise une croissance remarquable des ventes au cours des neuf premiers mois de 2026 et relève à nouveau ses prévisions pour l’exercice en cours

Indeterminate GlobeNewswire

12 hours ago

Pharming Group announces third quarter 2026 revenues above market expectations

Indeterminate GlobeNewswire

12 hours ago

argenx Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

12 hours ago

Molecular Partners Nominates MP0730 as Next Candidate in Expanding Pipeline of Radiotherapeutics, Targeting CD70

Indeterminate GlobeNewswire